Orynn-D Capsule PR
Marketer
Morningg Life Pharmaceuticals Pvt Ltd
Salt Composition
Domperidone (30mg) + Pantoprazole (40mg)
Overview Orynn-D Capsule PR
Gastroesophageal reflux disease (GERD), dyspepsia, and gastritis are effectively managed with the prescription medication, Orynn-D Capsule PR. This medicine alleviates symptoms by decreasing stomach acid production, thus relieving heartburn, abdominal pain, and irritation. Orynn-D Capsule PR further neutralizes existing stomach acid and facilitates gas expulsion, easing discomfort. Administered on an empty stomach, dosage and duration are determined by your physician based on individual needs and response. Continuous use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Complete disclosure of all other medications to your healthcare provider is essential due to potential interactions. Common, generally transient side effects include diarrhea, nausea, abdominal pain, flatulence, dry mouth, and headache. Report any concerns to your doctor immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to increased drowsiness risk. Dietary adjustments, such as consuming cool milk and abstaining from hot beverages, spicy foods, and chocolate, may enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any kidney or liver conditions, and if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Orynn-D Capsule PR
Managing gastroesophageal reflux, indigestion, and gastritis.
Major Benefits of Orynn-D Capsule PR:
Follow your doctor's instructions or refer to the product label for guidance. Take Orynn-D Capsule PR on an empty stomach.
Common Side effects of Orynn-D Capsule PR:
- Diarrhea
- Stomach pain
- Flatulence
- Dryness in mouth
- Dizziness
- Headache
How to use Orynn-D Capsule PR:
Follow your doctor's instructions or consult the product label for proper administration. Take Orynn-D Capsule PR on an empty stomach.
How Orynn-D Capsule PR works:
Orynn-D Capsule PR combines Domperidone and Pantoprazole to alleviate digestive discomfort. Domperidone, a prokinetic agent, enhances upper gastrointestinal motility, facilitating smoother food passage. Pantoprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Use of Orynn-D Capsule PR with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Orynn-D Capsule PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCAUTION
Mothers who are breastfeeding should exercise caution when using Orynn-D Capsule PR. Breastfeeding should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Orynn-D Capsule PR can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Orynn-D Capsule PR with care; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Orynn-D Capsule PR in individuals with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Orynn-D Capsule PR :
Should you forget a dose of Orynn-D Capsule PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Orynn-D Capsule PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |




